Search

Search Constraints

You searched for: Author/Creator Mohr, Raphael

Search Results

1. Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non‐obese HIV‐infected patients. (5th April 2019)

2. Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review. Issue 24 (18th June 2021)

4. Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis. Issue 3 (1st February 2021)

5. Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?. Issue 50 (December 2015)

6. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study. (November 2022)

7. MicroRNA‐200a: A stage‐dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients. Issue 1 (February 2017)

8. Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease. (7th May 2021)

9. Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis. Issue 17 (April 2018)